Eupraxia Pharmaceuticals Inc. (EPRX)

NASDAQ: EPRX · Real-Time Price · USD

8.31

+0.11 (1.34%)

At close: Jan 13, 2026, 4:00 PM EST

8.35

+0.04 (0.48%)

After-hours: Jan 13, 2026, 5:26 PM EST

Eupraxia Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Jan '26 Jan 13, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Market Capitalization	421	112	111	58	28	-	Upgrade
Market Cap Growth	279.11%	0.65%	90.50%	111.19%	-	-	Upgrade
Enterprise Value	363	102	96	43	8	-	Upgrade
Last Close Price	8.31	3.17	4.16	2.69	2.30	-	Upgrade
PB Ratio	4.76	3.51	124.32	8.08	1.83	-	Upgrade
P/TBV Ratio	7.23	65.70	50.06	7.48	1.75	-	Upgrade
Debt / Equity Ratio	0.00	0.00	11.71	1.25	0.52	-0.59	Upgrade
Quick Ratio	23.38	10.74	1.01	6.00	13.38	0.03	Upgrade
Current Ratio	23.98	11.10	1.02	6.08	13.49	0.05	Upgrade
Return on Equity (ROE)	-61.02%	-157.31%	-715.19%	-178.04%	-	-	Upgrade
Return on Assets (ROA)	-36.21%	-61.14%	-88.37%	-52.20%	-68.51%	-59.25%	Upgrade
Return on Capital (ROIC)	-38.47%	-78.03%	-126.40%	-58.41%	-110.75%	-	Upgrade
Return on Capital Employed (ROCE)	-33.60%	-84.80%	-3120.70%	-109.70%	-61.90%	10.70%	Upgrade
Earnings Yield	-7.52%	-22.84%	-25.44%	-31.75%	-68.66%	-	Upgrade
FCF Yield	-5.99%	-26.96%	-18.77%	-25.12%	-43.73%	-	Upgrade
Buyback Yield / Dilution	-13.17%	-40.52%	-25.21%	-55.45%	-102.75%	-0.01%	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q